An innovative 'safety switch' for CAR T-cell therapy, designed at the Malaghan Institute and recently patented, has the potential to significantly enhance the safety and accessibility of this cutting-edge cancer immunotherapy and
https://ibit.ly/zwOD5
https://ibit.ly/0VmbT
https://ibit.ly/XdAbP
https://twtr.to/A4lRd
https://ibit.ly/kbsKW